Sertraline for social phobia: a double-blind, placebo-controlled crossover study

10.1001/archpsyc.1994.03950010008002

10.1159/000414022

10.1016/0165-0327(87)90022-X

Liebowitz MR, Gulley R

Lydiard RB, 1988, J Clin Psychiatry, 49, 17

10.1176/ajp.145.5.590

10.1097/00004714-199312000-00008

10.1097/00004714-199006000-00024

McGlynn TJ, Metcalf HL: Diagnosis and Treatment of Anxiety Disorders: A Physician's Handbook. Washington, can Psychiatric Press, 1989, pp93-96

10.1001/archpsyc.1985.01790300097013

1993, Br J Psychiatry, 163, 40, 10.1192/S0007125000292362

Wernicke JF, Dornseif BE

Bull 1987;

Dunner DL, 1992, J Clin Psychiatry, 53, 21

10.1097/00004714-199202000-00018

10.1097/00004714-199208000-00022

Van Ameringen M, 1993, J Clin Psychiatry, 54, 27

Van Ameringen M, 1994, Neuropsychopharmacology, 10, 1965

Czepowicz VD, 1994, 147th Annual Meeting of the American Psychiatnc Association

Munjack D: Zoloft (sertraline) in the treatment of social phobia (abstract). Neuropsychopharmacology 1994; 10(suppl 3, part 2): I 965

10.1007/BF02244762

10.1192/bjp.134.4.382

Davidson JRT, 1991, Wilson W: The Brief Social Phobia Scale.J Clin Psychiatry, 52, 48

10.1016/0005-7967(79)90041-X

Sheehan DV: The Anxiety Disease. New York, Bantam, I 983, p138

Stewart AL, 1988, Med Cane, 26, 724

Liebowitz MR, 1988, J Clin Psychiatry, 49, 242

10.1111/j.1365-2125.1979.tb05903.x

10.1093/biomet/37.3-4.256

10.1207/s15327752jpa6301_14

10.1038/clpt.1993.64

10.1177/106002809202600303

10.1176/ajp.145.12.1521

10.1097/00004714-199106000-00024

10.1192/bjp.161.3.353

10.1001/archpsyc.1995.03950160039008

10.1037/1040-3590.4.3.329

10.1037/1040-3590.2.1.56

10.1037/1040-3590.5.4.487